Advertisement

Topics

Stora Enso to divest its Barcelona mill in Spain

20:00 EDT 26 Jul 2015 | Globe Newswire

HELSINKI, Finland, July 27, 2015 (GLOBE NEWSWIRE) -- Stora Enso has signed an agreement to divest its Barcelona mill, which produces recycled-fibre based consumer board, to the private equity fund Quantum. The transaction is in line with Stora Enso's strategy to focus its consumer board offering on high quality virgin-fibre products.

The initial cash consideration for the divestment of the shares is approximately EUR 10 million, subject to customary closing day adjustments. The transaction has no material income statement impact and is expected to be completed in the fourth quarter of 2015, subject to regulatory approvals.

"Stora Enso is focusing its consumer board offering on high quality virgin-fibre products. The Barcelona mill is the only recycled-fibre based mill in our Consumer Board division. Despite positive results development in recent months, the Barcelona mill requires further development effort and investment if it is to remain on a profitable path. I believe that the mill can operate more efficiently under the new ownership," says Jari Latvanen, Head of Consumer Board division.

Based on the annual figures for 2014, the divestment is expected to reduce Stora Enso's annual sales by EUR 117 million and simultaneously decrease Stora Enso's annual board production capacity by approximately 195 000 tonnes. The transaction does not have material impact on Stora Enso's operational EBIT and cash flow going forward and it will improve operational EBIT and EBITDA margins slightly. The Barcelona mill employs approximately 220 people.

About Quantum

Quantum Capital Partners is a German Private Equity fund headquartered in Munich. Quantum focuses on corporate spin-offs and carve-outs in which the acquisition target has a turnover between EUR 20 and 500 million and can benefit from Quantum's operational experience. Quantum has completed a series of successful transactions with leading global corporations such as BOSCH, BASF and AIRBUS Group. Quantum's current portfolio consists of seven companies, with a combined turnover of some EUR 350 million. Quantum commands a newly established fund of more than EUR 57 million and is an active investor in the industry, having completed five transactions in 2014 and two in 2015. www.quantum-capital-partners.com/

For further information, please contact:

Ulrika Lilja, EVP Global Communications, tel. +46 72 221 9228
Ulla Paajanen-Sainio, SVP Investor Relations, tel. +358 40 763 8767

Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wood and paper on global markets. Our aim is to replace non-renewable materials by innovating and developing new products and services based on wood and other renewable materials. We employ some 27 000 people in more than 35 countries, and our sales in 2014 were EUR 10.2 billion. Stora Enso shares are listed on NASDAQ OMX Helsinki (STEAV, STERV) and Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) on the International OTCQX over-the-counter market.www.storaenso.com

STORA ENSO OYJ

NEXT ARTICLE

More From BioPortfolio on "Stora Enso to divest its Barcelona mill in Spain"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...